Carmignac Gestion »

Apellis Pharmaceuticals shares owned by Carmignac Gestion

Quarter-by-quarter ownership of Apellis Pharmaceuticals shares owned by Carmignac Gestion from 13F filings

Historical chart of Carmignac Gestion investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Carmignac Gestion consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Carmignac Gestion

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 35k 40.23

More positions owned by Carmignac Gestion

NVIDIA Corporation (NVDA)
MercadoLibre (MELI)
S&p Global (SPGI)
Alphabet Cap Stk Cl A (GOOGL)
AmerisourceBergen (COR)
Amazon (AMZN)
McKesson Corporation (MCK)
Tradeweb Markets Cl A (TW)
Berkshire Hathaway CL B (BRK.B)
Block Cl A (XYZ)
Mastercard Cl A (MA)
salesforce (CRM)
Intercontinental Exchange (ICE)
Atlassian Corp Cl A (TEAM)
Broadcom (AVGO)

View all positions for Carmignac Gestion

Top funds holding Apellis Pharmaceuticals

BlackRock
venBio Select Advisor
Morgan Stanley
State Street Corporation
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
Deep Track Capital
Point72 Asset Management
Rtw Investments
HBK Investments
Suvretta Capital Management
Millennium Management
Geode Capital Management

View all funds holding Apellis Pharmaceuticals